Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report
This case study provides evidence for an integrated treatment strategy combining SIRT and HAIC with TKI and anti-PD-1 antibodies for patients with large HCC and microvascular invasion. Further confirmatory trials are required in the future.
Authors
- Hui Zhang
- Linbin Qiu
- Mingzhi Hao (ORCID: https://orcid.org/0000-0003-3173-1001)
- Qizhong Chen
- Yubin Hu (ORCID: https://orcid.org/0000-0002-3235-8483)
- Zhang-Xian Chen
- Jingfeng Liu (ORCID: https://orcid.org/0000-0003-3499-5678)
- Duanyu Lin
- Zhu-ting Fang (ORCID: https://orcid.org/0000-0003-3350-2210)
- Dechun Zheng (ORCID: https://orcid.org/0000-0001-8768-1627)
- Hailan Lin
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.4251/wjgo.v17.i3.100861
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00